CCR2 and medulloblastoma: In mice bearing Ptc medulloblastoma, combinatorial CCR2+HSCs + PD-1 also provided a significant survival benefit over both PD-1 only (p = 0.0001) and bulk HSC + PD-1 (p = 0.0005) (Fig. 8c).